|
PHF13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.663600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.238800E-01 |
| Normal-vs-Stage2 |
4.033700E-02 |
| Normal-vs-Stage3 |
2.838200E-01 |
| Normal-vs-Stage4 |
3.559000E-01 |
| Stage1-vs-Stage2 |
1.681650E-01 |
| Stage1-vs-Stage3 |
8.719800E-01 |
| Stage1-vs-Stage4 |
8.442400E-01 |
| Stage2-vs-Stage3 |
4.044600E-01 |
| Stage2-vs-Stage4 |
5.562000E-01 |
| Stage3-vs-Stage4 |
9.392600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.655600E-01 |
| Normal-vs-AfricanAmerican |
7.180200E-02 |
| Normal-vs-Asian |
2.013000E-01 |
| Caucasian-vs-AfricanAmerican |
2.692800E-01 |
| Caucasian-vs-Asian |
5.178200E-01 |
| AfricanAmerican-vs-Asian |
6.447400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.652030E-01 |
| Normal-vs-Female |
9.311200E-01 |
| Male-vs-Female |
1.120430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.598970E-01 |
| Normal-vs-Extreme_Weight |
2.092600E-01 |
| Normal-vs-Obese |
8.535000E-01 |
| Normal-vs-Extreme_Obese |
2.750400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.142800E-01 |
| Normal_Weight-vs-Obese |
9.569800E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.674000E-01 |
| Extreme_Weight-vs-Obese |
8.882000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.613200E-01 |
| Obese-vs-Extreme_Obese |
3.147000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.750400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.618400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.108010E-01 |
| Normal-vs-Age(81-100Yrs) |
1.137200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.374390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.228300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.416300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.034000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.776400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.672400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.682200E-01 |
| Normal-VS-Type2 PRCC |
2.142400E-03 |
| Normal-VS-KIRP CIMP |
5.989600E-02 |
| Normal-VS-Unclassified PRCC |
6.509200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.055900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.145870E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.343000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.71229999999768E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.495760E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.030200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.481100E-03 |
| Normal-vs-N1 |
3.559400E-01 |
| Normal-vs-N2 |
1.455570E-01 |
| N0-vs-N1 |
1.675220E-01 |
| N0-vs-N2 |
6.504900E-03 |
| N1-vs-N2 |
8.293700E-02 |
|
|
